| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T109 |
0-289 |
Sentence |
denotes |
In summary, our study supports the recommendation that clinicians must remain vigilant for potential acute and chronic complications of COVID-19 when caring for patients with Parkinson disease and other movement disorders because of the inherent vulnerabilities of this patient population. |
| T110 |
290-486 |
Sentence |
denotes |
Our cohort yielded several interesting observations that either confirmed or negated previous assumptions and findings reported regarding COVID-19 in patients with PD and other movement disorders. |
| T111 |
487-650 |
Sentence |
denotes |
Within a large database of inpatient cases throughout our hospital system, people with PD and parkinsonism accounted for only 2% of patients admitted for COVID-19. |
| T112 |
651-818 |
Sentence |
denotes |
However, for patients with movement disorders, the likelihood of hospitalization after contracting COVID-19 was three times higher than that of the general population. |
| T113 |
819-1013 |
Sentence |
denotes |
Furthermore, we found that older age, PD diagnosis, living in an extended care facility, comorbid dementia, and comorbid medical conditions were associated with more serious morbidity and death. |
| T114 |
1014-1258 |
Sentence |
denotes |
Even so, the mortality rate for patients with PD or dementia in this cohort was significantly less than the mortality previously reported in patients with other high-risk comorbidities, although higher than that reported in general populations. |
| T115 |
1259-1458 |
Sentence |
denotes |
We also noted that patients with movement disorders frequently presented with altered mental status, generalized weakness, or worsening mobility, but not anosmia, as the initial symptoms of COVID-19. |
| T116 |
1459-1654 |
Sentence |
denotes |
Lastly, within this limited dataset, we did not observe that amantadine or memantine afforded distinct protective properties against COVID-19, as was suggested in the paper by Redjak et al. [24]. |
